Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.36
(-5.33%)
HKD 0.36
(-5.33%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - CNY | 0.0% |
| 2022 | - CNY | -100.0% |
| 2021 | 69 Thousand CNY | -66.01% |
| 2020 | 203 Thousand CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - CNY | 0.0% |
| 2024 Q1 | - CNY | 0.0% |
| 2023 Q1 | - CNY | 0.0% |
| 2023 FY | - CNY | 0.0% |
| 2023 Q4 | - CNY | 0.0% |
| 2023 Q3 | - CNY | 0.0% |
| 2023 Q2 | - CNY | 0.0% |
| 2022 Q1 | 71 Thousand CNY | 2.9% |
| 2022 Q4 | - CNY | 0.0% |
| 2022 FY | - CNY | -100.0% |
| 2022 Q2 | 71 Thousand CNY | 0.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2021 Q4 | 69 Thousand CNY | 0.0% |
| 2021 Q3 | 69 Thousand CNY | 137.93% |
| 2021 Q2 | 29 Thousand CNY | 0.0% |
| 2021 FY | 69 Thousand CNY | -66.01% |
| 2021 Q1 | 29 Thousand CNY | -85.71% |
| 2020 Q4 | 203 Thousand CNY | -29.51% |
| 2020 FY | 203 Thousand CNY | 0.0% |
| 2020 Q3 | 288 Thousand CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 107.05 Million HKD | 100.0% |